WebMycophenolate (CellCept) is used with other medications to help prevent transplant organ rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in adults and children 3 months of age and older who have received kidney, heart, or liver transplants. WebWhat it is used for CellCept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. CellCept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to …
Mycophenolate: Dosage, Mechanism/Onset of Action, Half-Life
WebJan 23, 2024 · Cellcept is a prescription medicine used to treat the symptoms of organ rejection after a Kidney Transplant, Heart Transplant or a Liver Transplant. Cellcept … WebAccording to renal transplant guidelines, mycophenolate is the suggested first-line antiproliferative agent to be used for initial maintenance immunosuppression in combination with other immunosuppressive agents, which may include a calcineurin inhibitor such as tacrolimus, corticosteroids, and induction therapy with basiliximab or anti-thymocyte … camembert sondage
PRODUCT MONOGRAPH INCLUDING PATIENT …
WebCellCept ® (mycophenolate mofetil) is a prescription medicine to prevent rejection (antirejection medicine) in people who have received a kidney, heart or liver transplant. Rejection is when the body’s immune system perceives the new organ as … WebMycophenolate mofetil is a member of the selective immunosuppressants drug class and is commonly used for Autoimmune Hepatitis, Bullous Pemphigoid, Cogan's Syndrome, and others. Brand names for mycophenolate mofetil include CellCept . WebMycophenolic acid is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus. Specifically it is used following kidney, heart, and liver transplantation. It can be given by mouth or by injection into a vein. It comes as mycophenolate sodium and … coffeemonsterzco etsy